28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The morphologic evolution of necrotic pancreatic fluid collections and their management. Asymptomatic: delay, defer and don’t panic!

      editorial

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pancreatic necrosis is a serious complication of acute pancreatitis (AP) that occurs in 10-20% of patients. It is a local complication involving pancreatic parenchyma, surrounding soft tissue and possibly extending to adjacent organs. Societal guidelines acknowledge pancreatic necrosis to be a marker for severity, associated with greater length of hospitalization, need for invasive interventions, mortality, and elevated risk for readmission following discharge when contrasted to patients with interstitial pancreatitis [1,2]. Pancreatic necrosis is associated with fluid collections. The revised Atlanta Classification distinguishes fluid collections in the setting of AP into two categories: collections that occur in the setting of interstitial pancreatitis or in the setting of pancreatic necrosis. Collections found in the setting of pancreatic necrosis are further categorized based on their maturity. Acute necrotic collections (ANC) are found within the first month following acute necrotizing pancreatitis and generally lack organization/coherent architecture. These collections progressively develop a well-defined wall, i.e. walled-off necrosis (WON) [3]. The amount of solid debris contained with ANC and WON varies. The revised Atlanta classification recommends that the term pseudocyst (PC) stringently be avoided for collections that contain any degree of solid, necrotic material. The degree to which the presence of solid debris establishes a pancreatic/peri-pancreatic fluid collection to be necrotic in origin is by no means reliable. One study evaluating CT findings in a cohort of patients managed with endoscopic therapy for fluid collections in the setting of AP reported CT evidence of solid debris to be more frequent in those ultimately diagnosed with WON. However, only 45% of patients with established WON had identifiable solid debris on CT scan imaging [4]. MRI and EUS may be more effective modalities for identifying a complex collection in the setting of pancreatic necrosis, possibly not without limitations as well [5-8]. Importantly, beyond the limitations of imaging, very little is known about the natural history of fluid collections in the setting of necrotizing pancreatitis in the absence of intervention. Smaller collections (<4 cm) in the absence of pancreatic duct disruption are more likely to resolve; however, the available literature does not clearly delineate which fluid collections are in the setting of pancreatic necrosis [8-10]. Rana et al in this issue of Annals of Gastroenterology offer to us an intriguing assessment of the natural history of ANC and WON in the form of a prospective cohort study [11]. The authors enrolled patients with persistent fluid collections at 6 weeks on non-invasive imaging following necrotizing pancreatitis in a program of serial EUS surveillance at 6 week, 3 and 6 month intervals. Forty-seven patients were initially enrolled with the majority of them having radiographic evidence of extensive pancreatic injury (87% with >30% pancreatic gland necrosis) and all having evidence of pancreatic fluid collections at a 6-week interval. Collections at the time of first (6-week) EUS assessment were large (median 10 cm) and the majority of patients (87%) had solid debris. Of interest, the authors documented a heterogeneous group of outcomes for patients that were followed longitudinally. First, of the 47 patients, 5 (11%) had complete resolution of their collections without intervention over 6 months. Eleven (23%) patients ultimately required endoscopic drainage presumably for attributing symptoms. Finally, in those patients with persistent collections that returned for repeat EUS exams throughout the duration of the study, the size of the collections decreased and solid debris was present in less than 50% at 6-month surveillance interval. A substantial proportion of the study cohort (22 patients, 47%) did not return for all surveillance EUS exams, which is a limitation of the study. Also, details of the indications for those patients that underwent endoscopic intervention are missing. However, in spite of these limitations one may draw helpful conclusions from this study. First, this study clearly supports what we are all beginning to realize about necrotizing acute pancreatitis. Such patients represent a heterogeneous group with respect to short and long term outcomes. It is clear that a substantial number of patients in this cohort required an invasive intervention for persistent, symptomatic collections (11, 23%). The majority of the endoscopic interventions were performed within the 6- to 18-week interval (7/11). However, a large proportion of the overall cohort (14, 30%) did not require an intervention at 6 months, with the majority of these collections having either resolved, diminished in size, or fully liquefied. While it is difficult to make any assumptions on the 22 patients that were lost to follow up over 6 months, we can conclude that at least 60% of the cohort did not require an intervention at the 3-month interval imaging, with the collections in this subgroup of the cohort becoming liquefied and/or diminishing in diameter. This data certainly supports the fact that solid, necrotic debris within WON is dynamic, often liquefies and is potentially resorbed with time. Second, these findings may have some import for medical decision making with reference to management of these patients. Our impression is that they further reinforce a strategy of watching and delaying when it comes to invasive interventions such as endoscopic drainage and/or necrosectomy; especially in the absence of debilitating symptoms. It is now well established that a delay and a minimally invasive approach in patients with WON translates to fewer complications and better outcomes [12-14]. With the knowledge from this study that an intervention can be either averted or delayed beyond 6 months in a significant proportion of patients with WON, we feel all that more confident with this conservative strategy. Additionally, based on large endoscopic series with varying median time intervals from sentinel AP to intervention, allotting these collections ample time to liquefy and mature may be associated with a greater likelihood of technical, recurrence-free success and possibly even lower procedure burden. However, more prospective research is needed to substantiate this theory [15-17]. Overall, this study, in spite of its limitations, adds to our understanding of the natural history of pancreatic fluid collections in the setting of acute necrotizing pancreatitis. A substantial proportion of ANC and WON will liquefy, diminish in size, and possibly even resolve spontaneously, though the exact proportion remains to be established. This study offers a convincing argument that there is a subset of patients with necrotic peripancreatic/pancreatic fluid collections that do not require intervention in spite of extensive pancreatic parenchymal injury. It also promotes the strategy of expectant management and radiographic surveillance, deferring early invasive interventions in the absence of debilitating symptoms or infection.

          Related collections

          Most cited references15

          • Record: found
          • Abstract: not found
          • Article: not found

          Acute pancreatitis: bench to the bedside.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study).

            As with endoscopic transmural drainage of peripancreatic fluid collections, the same transluminal access can be expanded to introduce an endoscope through the gastrointestinal wall into the retroperitoneum and remove infected pancreatic necroses under direct visual control. This study reports the first large series with long-term follow-up. Data for all patients undergoing transluminal endoscopic removal of (peri)pancreatic necroses between 1999 and 2005 in six different centres were collected retrospectively, and the patients were followed up prospectively until 2008. The initial patient and treatment outcome data were recorded, as were long-term results. Ninety-three patients (63 men, 30 women; mean age 57 years) underwent a mean of six interventions starting at a mean of 43 days after an attack of severe acute pancreatitis. After establishment of transluminal access to the necrotic cavity and subsequent endoscopic necrosectomy, initial clinical success was obtained in 80% of the patients, with a 26% complication and a 7.5% mortality rate at 30 days. After a mean follow-up period of 43 months, 84% of the initially successfully treated patients had sustained clinical improvement, with 10% receiving further endoscopic and 4% receiving surgical treatment for recurrent cavities; 16% suffered recurrent pancreatitis. Direct transluminal endoscopic removal of pancreatic necroses is associated with good long-term maintenance of the high initial efficacy; complications can occur, with an associated mortality of around 7.5%. Further studies are necessary in order to optimise endotherapy and define its role in relation to surgery in the clinical management of such patients.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Direct endoscopic necrosectomy for the treatment of walled-off pancreatic necrosis: results from a multicenter U.S. series.

              Direct endoscopic necrosectomy (DEN) for treatment of walled-off pancreatic necrosis (WOPN) has been performed as an alternative to operative or percutaneous therapy. To report the largest combined experience of DEN performed for WOPN. Retrospective chart review. Six U.S. tertiary medical centers. A total of 104 patients with a history of acute pancreatitis and symptomatic WOPN since 2003. DEN for WOPN. Resolution or near-resolution of WOPN without the need for surgical or percutaneous intervention and procedural complications. Successful resolution was achieved in 95 of 104 patients (91%). Of the patients in whom it failed, 5 died during follow-up before resolution, 2 underwent operative drainage for persistent WOPN, 1 required surgery for massive bleeding on fistula tract dilation, and 1 died periprocedurally. The mean time to resolution from the initial DEN was 4.1 months. The first débridement was performed a mean of 63 days after the initial onset of acute pancreatitis. In 73%, the entry was transgastric with median tract dilation diameter of 18 mm. The median number of procedures was 3 with 2 débridements. Complications occurred in approximately 14% and included 5 retrogastric perforations/pneumoperitoneum, which were managed nonoperatively. Univariate analysis identified a body mass index >32 as a risk factor for failed DEN. Retrospective, highly specialized centers. This large, multicenter series demonstrates that transmural, minimally invasive endoscopic débridement of WOPN performed in the United States is an efficacious and reproducible technique with an acceptable safety profile. Copyright © 2011 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Ann Gastroenterol
                Ann Gastroenterol
                AnnGastroenterol
                Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
                Hellenic Society of Gastroenterology (Greece )
                1108-7471
                1792-7463
                2014
                : 27
                : 3
                : 191-192
                Affiliations
                [a ]Division of Gastroenterology, Washington University, St. Louis MO (Jeffrey Easler), USA
                [b ]Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA (Georgios I. Papachristou) USA
                Author notes
                Correspondence to: Georgios Papachristou, MD, Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, GI Administration, Mezzanine Level 2, C Wing, UPMC Presbyterian Hospital, 200 Lothrop Street, Pittsburgh PA 15213, United States, e-mail: papachri@ 123456pitt.edu
                Article
                AnnGastroenterol-27-191
                4073012
                f55fcc01-91f2-4e4b-a200-d1da03b73f88
                Copyright: © Hellenic Society of Gastroenterology

                This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 01 May 2014
                : 02 May 2014
                Categories
                Editorial

                Comments

                Comment on this article